The US equities markets were volatile today, and mostly bearish, as traders weigh the probable outcome of a looming government shutdown. At the center of the debate is the proposed border wall, which at under $6B in funding is not a very large expense, particularly if there is a reduction in military operations in Syria and Afghanistan. However, it seems clear that the primary issue is political, and for this reason, we can realistically expect a protracted battle. Meanwhile, we saw a huge move up in Obalon Therapeutics (OBLN) after the company announced FDA approval of its flagship product. Here’s a recap.
